MarketInOut Stock Screener Log In | Sign Up

argenx SE ADR

NASDAQ • Healthcare • Biotechnology • Quote as of 11/20/2026
argenx SE ADR stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization59,586 mln
Float62.76 mln
Earnings Date02/25/2027

EPS

28.87
Exceptional

P / E

32.06
Overvalued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-1.71
Likely manipulated

1-Year Forecast

1,150.61
Attractive

Relative Strength

84 / 100
Strongly outperforming

Business Description

argenx SE is a Netherlands-based biopharmaceutical company focused on treating autoimmune diseases, operating across the United States, Japan, China, and other markets worldwide. Its two approved medicines, VYVGART and VYVGART HYTRULO, are used to treat several serious immune conditions, including generalized myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy. The company is also advancing a broad pipeline of experimental treatments targeting a range of additional autoimmune and inflammatory diseases. Founded in 2008 and headquartered in Amsterdam, argenx works with partners such as Zai Lab, Halozyme, and AbbVie to develop and bring its therapies to patients.

Key Fundamentals

EPS28.87
P/E32.06
ROE23.58
RPS3.80
ROIC47.71
ROA19.88
Interest Cover394
EBITDA, mln1,789
EV / EBITDA30.50
EV / EBIT31.06
Revenue, mln5,222
EV / Revenue10.45

Quote Details

Last 925.70
Change -16.34 (-1.73%)
Open 943.02
Volume 236,017
Turnover 218,480,944
Average Volume 338,768

Financial Ratios

Pre-Tax Profit Margin34
Leverage Ratio1.19
Current Ratio5.12
Price / Book6.57
Price / Tangible Book6.79
Price / Cash Flow60.51
Price / Free Cash Flow52.42
Debt / Equity0.01
Price / Sales11.39
PEG Ratio1.29

Financial Strength

Altman Z-Score27.24
Piotroski F-Score 5 / 9
Beneish M-Score-1.71
Price to Intrinsic Value18.88
Price to Graham Number3.24
1-Year Target Price1,150.61
Short Ratio2.95
Short % of Float2.25

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.58% 68 / 100   
1 Month 5.7% 93 / 100   
2 Months -6.29% 64 / 100   
6 Months 14.79% 91 / 100   
1 Year 1.21% 55 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog